Clinical Trial Update: Safety and Efficacy of SPARC1203 in Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of SPARC1203 in allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• SPARC1203

Snippet

Sponsor: Sun Pharma Advanced Research Company Limited | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED